GL1X · GenesisL1 explorer

MolNFT v1 · #84501 · protein

Inhibitors of JAK2 kinase domain

3ZMM · Tyrosine-protein kinase JAK2: “Inhibitors of JAK2 kinase domain”. X-ray diffraction, 2 ligands (ACE, F9J), 5 pockets (best druggability 0.67). MolNFT v1 #84501 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3ZMM
Type
protein
Length
551 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2, 2.7.1.112
UniProt
O60674
Ligands
ACE, F9J
Pockets
5 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2, 2.7.1.112)protein27545% helix, 17% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.10.2, 2.7.1.112)protein27646% helix, 17% strandO60674

Ligands and binding sites

  • ACE · Acetyl group · ligand · 3 copies · chains A, B
  • F9J · 5-fluoro-4-[(1S)-1-(5-fluoropyrimidin-2-yl)ethoxy]-N-(5-methyl-1H-pyrazol-3-yl)-6-morpholino-pyrimidin-2-amine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17650.670.7557empty
22080.600.8129F9J
33220.590.7744F9J
41510.570.8227empty
5640.300.7418empty

Interfaces

1 interface between chains.

  • A–B · 335 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 3ZMM · Inhibitors of Jak2 Kinase domain · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.